πŸ‡ΊπŸ‡Έ FDA
Patent

US 10208100

Angiopoietin-2 specific TIE2 receptor

granted A61KA61K38/177A61K38/179

Quick answer

US patent 10208100 (Angiopoietin-2 specific TIE2 receptor) held by United Kingdom Research and Innovation expires Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United Kingdom Research and Innovation
Grant date
Tue Feb 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K38/177, A61K38/179, A61P, A61P27/02